StockNews.com began coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Stock Down 6.6 % Shares of BLCM opened at $0.07 on Friday. The business’s 50 day moving average is $0.08 and […]
StockNews.com assumed coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Stock Down 6.6 % NASDAQ:BLCM opened at $0.07 on Friday. The stock’s 50-day simple moving average is $0.08 and its 200 […]
StockNews.com assumed coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a report released on Saturday. The firm issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Trading Down 6.6 % Shares of BLCM stock opened at $0.07 on Friday. Bellicum Pharmaceuticals has a 12 month low of $0.06 and a […]
Bellicum Pharmaceuticals (NASDAQ:BLCM) Receives New Coverage from Analysts at StockNews.com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
The University of Texas MD Anderson Cancer Center today announced it has acquired certain assets from Bellicum Pharmaceuticals, Inc. related to the CaspaCIDe switch platform and the GoCAR platform.